Natural Sleep Aid Linked to Heart Failure

The sleep supplement marketed as “natural” is now tied to a very unnatural outcome: a sharply higher rate of heart failure in long-term users with insomnia.

Quick Take

A massive real-world analysis of more than 130,000 adults with insomnia linked long-term melatonin use to significantly worse heart outcomes.
Researchers reported higher incident heart failure, more heart-failure hospitalizations, and higher all-cause mortality over five years among long-term users.
The data show association, not proof of causation, and the study had not yet gone through peer review at the time of the presentation.
The findings challenge the “safe because it’s over-the-counter” assumption and push consumers toward common-sense restraint.

The Melatonin Trap: When “Over-the-Counter” Becomes “Overconfident”

Chronic insomnia makes people desperate, and melatonin has become the quiet nightly ritual that feels safer than prescription pills. The new concern comes from a multinational cohort study drawn from TriNetX electronic health records, averaging about age 56, focused specifically on adults with insomnia. Long-term use was defined as at least a year, and the comparison group was matched non-users. The striking part was not grogginess or weird dreams, but serious cardiovascular outcomes.

The reported numbers are the kind that force even skeptics to sit up: roughly a 90% higher hazard of incident heart failure, a much higher rate of heart-failure hospitalizations, and about double the risk of death from any cause over five years. Researchers adjusted for major confounders, and sensitivity checks still found the same direction and magnitude. The public-facing message stayed careful: this is a red flag, not a conviction.

What the Study Actually Found, and Why It Hit a Nerve

Melatonin has floated in a cultural sweet spot: familiar, cheap, “natural,” and not treated like a serious drug. That halo makes any signal of harm feel like betrayal. The analysis compared tens of thousands of long-term melatonin users to similar adults with insomnia who did not use it long-term, then tracked outcomes over years. The attention-grabber was heart failure, because it’s not a nuisance side effect; it’s a life-changing diagnosis.

The study’s framing matters. It targeted people with insomnia, not the occasional jet-lag traveler. It measured “real-world” outcomes rather than lab sleep metrics. It also arrived through a major cardiology stage, presented at the American Heart Association Scientific Sessions in Dallas in November 2025, rather than emerging quietly in a sleep journal. That pipeline adds visibility, but it also means the findings were still preliminary at the time of coverage.

Association Is Not Causation

Observational data can’t prove melatonin caused heart failure. People who take melatonin nightly for years may differ from non-users in ways no database fully captures. Severe insomnia itself correlates with stress hormones, depression or anxiety, weight gain, blood pressure issues, and late-night habits that don’t show up neatly in coding.

That’s where the “natural” label becomes dangerous marketing shorthand. Over-the-counter status in the U.S. can lull consumers into thinking they’re dealing with something gentle, like herbal tea. Supplements can vary in content, dosing habits drift upward, and people keep taking them without follow-up because no one is “managing” the medication. A serious study finding serious outcomes should trigger the same discipline people use with any long-term health decision.

The Real Target: Nightly, Long-Term Use Without a Plan

Short-term melatonin use has long been treated as relatively safe, and major medical sources still emphasize uncertainty about long-term effects rather than guaranteed danger. That distinction matters because many adults aren’t using it for a week; they’re using it for years. The newer analysis doesn’t say, “Never touch melatonin.” It says, “Chronic nightly use in insomnia patients tracked with worse cardiovascular outcomes.” That’s a different, more urgent conversation.

Experts quoted in coverage leaned toward practical dosing restraint, often pointing to low doses in the 1–3 mg range and timing it before bed. That advice reflects a broader principle: if someone must experiment with melatonin, treat it like a tool, not a lifestyle. Use the smallest amount for the shortest time, reassess frequently, and don’t ignore the root cause of insomnia. Sleep problems often respond better to consistent routines than to escalating supplements.

What Readers Over 40 Should Do Tomorrow Morning

Heart failure risk grabs attention because age is already a risk multiplier. Many adults over 40 juggle weight, blood pressure, blood sugar, or sleep apnea without perfect control, and insomnia piles on. The best move is not panic; it’s a hard inventory. If melatonin has become automatic, ask why. Is the dose creeping? Are you masking an undiagnosed sleep disorder? Do you rely on it because your evenings are wired with alcohol, screens, or stress?

Take the next step with a clinician who won’t dismiss supplements as harmless or demonize them as poison. Bring the bottle, the dose, and the timeline. Ask directly about cardiovascular risk, drug interactions, and whether you should taper or stop. If you continue, set boundaries: a time-limited trial, a low dose, and a focus on sleep fundamentals.